Cartesian Therapeutics Inc

NASDAQ:RNAC   4:00:00 PM EDT
9.83
+0.07 (+0.72%)
4:10:52 PM EDT: $10.05 +0.22 (+2.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)255.14M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.9 Million
Adjusted EPS-$0.82
See more estimates
10-Day MA$10.04
50-Day MA$10.56
200-Day MA$16.28
See more pivots

Cartesian Therapeutics Inc Stock, NASDAQ:RNAC

704 Quince Orchard Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.617.923.1400
Number of Employees: 38

Description

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.